stent insertion using percutaneous transhepatic biliary drainage (PTBD) or endoscopic retrograde biliary drainage is a widely accepted palliative procedure with the intent of symptomatic relief, such as obstructive jaundice. 5, 6 Biliary stent insertion could result in slightly improved prognosis of patients by prevention of biliary stasis and hepatic failure.
However, dysfunction of a biliary stent often occurs due to clogging of the stent lumen by biliary sludge, tumor ingrowth, or tumor overgrowth. 7 In order to reduce the incidence of dysfunction of a biliary stent, radiation therapy (RT) is used. In addition, RT is also used for the purpose of improving the prognosis of patients with cholangiocarcinoma because cholangiocarcinoma does not show a good response to chemotherapy, and effective regimens have not been studied well. 8 The types of RT used include External beam radiation therapy (EBRT) and intraluminal brachytherapy (ILBT); these RT methods have been used separately or in conjunction. EBRT can reduce the tumor volume; however, there is a considerable problem in that approaching the tumoricidal dose is difficult because of the radiation tolerance limits of the adjacent organs. 9 ILBT has been increasingly applied in order to minimize radiation exposure to the adjacent organs and to apply localized high dose radiation on the tumor. 10 Many studies have demonstrated and accepted that treatment of advanced inoperable cholangiocarcinoma using only ILBT has limited effectiveness due to frequent recurrences within the non-irradiated portion of the bile duct.
Therefore, treatment with ILBT only has been used restrictively in small carcinomas that do not spread beyond the extrahepatic bile duct. 11 However, the effect of combination of EBRT with ILBT remains controversial. Shin et al. 9 reported that combined use of EBRT and ILBT is an effective method for improving the treatment outcome in patients with inoperable carcinoma of the extrahepatic bile ducts. On the other hand, according to a recent retrospective trial, RT improved patient prognosis and the patency of uncovered metallic stents, however, ILBT provided no additional benefits. 12 Consequently, the aim of this study is to prove the validity of ILBT with comparison of the effect of EBRT along with ILBT and the effect of EBRT alone in patients with advanced hilar cholangiocarcinoma. In addition, we attempted to determine how the stent patency was improved by ILBT.
METHODS

Patients
Between the obstructive lesion for maintenance of biliary tracts.
Placement of a metal stent through the same route with biliary drainage was attempted. In one patient, placement of the stent using the same route used with the endoscopic method failed, therefore, the patient underwent stent placement using PTBD. Twelve patients were treated with EBRT alone (Group 1) and nine patients were treated with combined EBRT and ILBT (Group 2) (Fig. 1) . A summary of the patients' characteristics is shown in Table 1 .
Radiation therapy
EBRT was performed using a 10-MV X-ray unit, using the ILBT was performed using 192 Ir, which was positioned in order to encompass the tumor with an approximate 2-cm margin proximally and distally. The median dose delivered was 18 Gy with 6 Gy per fraction and was performed three times.
Follow up
Patient symptoms and blood tests were assessed each time 
End point
The If the patient died with a remaining patent stent, the data on stent patency were censored.
Statistical evaluation
Comparisons between groups were evaluated using Kaplan-Meier, and statistical significance was evaluated using a log-rank test. The Mann-Whitney U -test was used for comparison of quantitative variables. The Spearman rank-order correlation coefficient was also used for comparison of irradiation dose with tendency of survival period and stent patency. Multivariate analysis using Cox regression analysis was also performed for evaluation of the prognostic significance of the covariates. p -values<0.05 were considered significant for all statistical analysis.
RESULTS
Characteristics of the patients
Between two groups, there were no differences in the ba- Fig. 2 ).
Cox regression analysis was performed for evaluation of factors, including age, sex, number of stents placed, stage, and stent insertion route, which could affect the survival period of patients. However, no correlation showed between these factors and survival period.
Stent patency
Overall stent patency period was 205 days (range 99-856).
The period for group 1 was 250 days (range 122-856), and that of group 2 was 133 days (range: 99-321, Table 2 ). However, no statistically significant difference was observed between the two (p =0.620) (Fig. 3) .
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Complications of radiotherapy
Gastric ulcer was observed in three patients, two in group 1, and one in group 2. All the patients with gastric ulcer were treated with anti-ulcer medication, and were treated completely. They did not require hospital admission and were treated in the outpatient clinic. Except gastric ulcer, there was no other complication induced by RT.
DISCUSSION
Despite the low incidence of hilar cholangiocarcinoma, it is a dreadful tumor because the diagnosis is commonly not made until the disease has advanced. Surgical treatment of the advanced hilar cholangiocarcinoma which is only curative treatment, such as hepatectomy and liver transplantation, is usually impossible. 1,2,13 Unfortunately, the median survival period of patients with advanced hilar cholangiocarcinoma is less than one year. 14 Therefore, variable meth- Cumulative stent patency rates were calculated using the Kaplan Meier method and compared using the log rank test. No signi cant di erence was observed between the two groups. EBRT, external beam radiation therapy; ILBT, intraluminal brachytherapy.
Fig. 2.
Cumulative survival rates of Group 1 and Group 2. Cumulative survival periods were calculated using the Kaplan Meier method and compared using the log rank test. No signi cant di erence was observed between the two groups. EBRT, external beam radiation therapy; ILBT, intraluminal brachytherapy. cancer has a low sensitivity to RT. 11 ILBT is also used on the assumption that it might have an effect on improving the prognosis by a mechanism similar to that of RT. 15 .65 p =0.065). We also attempted to determine the cut-off point of the effective radiation dose; however, it was impossible because the number of patients was too small to estimate. As a result, administration of the maximum irradiation dose might be an important factor in improving the patient survival period in treatment of inoperable cholangiocarcinoma, regardless of the method of radiation. However, this outcome was based on preliminary data using data from a small number of enrolled patients. Therefore, further studies will be needed in order to confirm our result or hypothesis.
In conclusion, the current study has shown that a 
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